{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T21:40:40Z","timestamp":1686001240590},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1568,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1600-0609.2011.01612.x","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T18:32:39Z","timestamp":1300732359000},"page":"541-545","source":"Crossref","is-referenced-by-count":7,"title":["Aplastic anemia successfully treated with rituximab: the possible role of aplastic anemia-associated autoantibodies as a marker for response"],"prefix":"10.1111","volume":"86","author":[{"given":"Hiroyuki","family":"Takamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Saikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","article-title":"Rituximab for the treatment of refractory autoimmune hemolytic anemia in children","volume":"101","author":"Zecca","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2006.06448.x","article-title":"Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13","volume":"136","author":"Scully","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","article-title":"Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study","volume":"112","author":"Godeau","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.seminhematol.2010.01.010","article-title":"Rituximab in autoimmune hematologic diseases: not just a matter of B cells","volume":"47","author":"Stasi","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood-2004-05-1839","article-title":"Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells","volume":"104","author":"Feng","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood-2006-07-036715","article-title":"Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia","volume":"109","author":"Takamatsu","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood.V96.6.2049","article-title":"Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia","volume":"96","author":"Kojima","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood.V78.5.1268.1268","article-title":"Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients","volume":"78","author":"Viale","year":"1991","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198501313120501","article-title":"Circulating activated suppressor T lymphocytes in aplastic anemia","volume":"312","author":"Zoumbos","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4049\/jimmunol.136.5.1629","article-title":"Establishment of an interleukin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis","volume":"136","author":"Herrmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0037-1963(00)90026-X","article-title":"Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia","volume":"37","author":"Young","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0609.2004.00259.x","article-title":"Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia","volume":"73","author":"Hara","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00277-005-1022-8","article-title":"Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia","volume":"84","author":"Dubey","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348","article-title":"Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party","volume":"85","author":"Bacigalupo","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","article-title":"Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia","volume":"85","author":"Rosenfeld","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2002-04-1134","article-title":"Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia","volume":"101","author":"Frickhofen","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.20428","article-title":"Aplastic anemia successfully treated with rituximab","volume":"80","author":"Hansen","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08076.x","article-title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases","volume":"149","author":"Cooper","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2006.08.016","article-title":"Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE","volume":"122","author":"Vallerskog","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1182\/blood-2002-11-3409","article-title":"Autoantibodies frequently detected in patients with aplastic anemia","volume":"102","author":"Hirano","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.2004.05317.x","article-title":"Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients","volume":"128","author":"Hirano","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00277-010-1020-3","article-title":"Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia","volume":"89","author":"Qi","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/intimm\/dxp058","article-title":"Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1\/2-dependent pathway","volume":"21","author":"Espinoza","year":"2009","journal-title":"Int Immunol"},{"key":"10.1111\/j.1600-0609.2011.01612.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.182.1.703","article-title":"Anti-moesin antibodies in the serum of patients with aplastic anemia stimulate peripheral blood mononuclear cells to secrete TNF-alpha and IFN-gamma","volume":"182","author":"Takamatsu","year":"2009","journal-title":"J Immunol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01612.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01612.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T21:09:58Z","timestamp":1685999398000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01612.x"}},"subtitle":["AA successfully treated with rituximab"],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01612.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,17]]}}}